Aries Science & Technology And Enveric Biosciences Announce Licensing Agreement; Eligible To Receive Milestone Payments Of Up To $61M On Future Sales, If All Conditions Met
Portfolio Pulse from Benzinga Newsdesk
Aries Science & Technology and Enveric Biosciences have announced a licensing agreement. Enveric Biosciences is eligible to receive milestone payments of up to $61 million on future sales if all conditions are met.
July 15, 2024 | 12:12 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Enveric Biosciences has entered into a licensing agreement with Aries Science & Technology, potentially earning up to $61 million in milestone payments based on future sales.
The licensing agreement with Aries Science & Technology could significantly boost Enveric Biosciences' revenue if the milestone conditions are met, positively impacting its stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100